We are live on ! Find out more
RG

Rathbones Group Portfolio holdings

AUM $27.1B
1-Year Est. Return 20.2%
This Fund
S&P 500
This Quarter Est. Return
+13.35%
1 Year Est. Return
+20.2%
3 Year Est. Return
+79.31%
5 Year Est. Return
+95.63%
10 Year Est. Return
+508.18%
AUM
$7.04B
AUM Growth
+$1.2B
Cap. Flow
+$508M
Cap. Flow %
7.21%
Top 10 Hldgs %
32.93%
Holding
400
New
27
Increased
145
Reduced
105
Closed
14

Top Buys

Rank Stock Value
1
ALGN icon
Align Technology
ALGN
+$68.4M
2
UBER icon
Uber
UBER
+$51.6M
3
C icon
Citigroup
C
+$34M
4
JKHY icon
Jack Henry & Associates
JKHY
+$28.3M
5
V icon
Visa
V
+$27.4M

Sector Composition

Rank Sector Weight
1 Technology 24.83%
2 Financials 17.64%
3 Consumer Discretionary 12.09%
4 Consumer Staples 11.97%
5 Communication Services 9.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWK icon
326
American Water Works
AWK
$26.3B
$307K ﹤0.01%
2,000
-150
-7% -$23.1K
XME icon
327
State Street SPDR S&P Metals & Mining ETF
XME
$4.05B
$307K ﹤0.01%
+9,190
New +$261K
SA
328
Seabridge Gold
SA
$2.8B
$306K ﹤0.01%
14,501
HCM icon
329
HUTCHMED
HCM
$1.89B
$303K ﹤0.01%
9,450
DHR icon
330
Danaher
DHR
$135B
$302K ﹤0.01%
+1,535
New +$308K
IXC icon
331
iShares Global Energy ETF
IXC
$2.71B
$299K ﹤0.01%
14,720
-1,459
-9% -$27.3K
MKL icon
332
Markel Group
MKL
$25B
$298K ﹤0.01%
288
+10
+4% +$9.97K
ALB icon
333
Albemarle
ALB
$13.5B
$292K ﹤0.01%
+1,980
New +$235K
SRNE
334
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$290K ﹤0.01%
42,484
TVRD
335
Tvardi Therapeutics
TVRD
$23.5M
$287K ﹤0.01%
528
VBR icon
336
Vanguard Small-Cap Value ETF
VBR
$37.1B
$284K ﹤0.01%
2,000
FNF icon
337
Fidelity National Financial
FNF
$13.9B
$281K ﹤0.01%
+7,488
New +$253K
RCKT icon
338
Rocket Pharmaceuticals
RCKT
$348M
$274K ﹤0.01%
+5,000
New +$182K
ADM icon
339
Archer Daniels Midland
ADM
$41.4B
$272K ﹤0.01%
5,395
EPAM icon
340
EPAM Systems
EPAM
$4.69B
$269K ﹤0.01%
750
VNQI icon
341
Vanguard Global ex-US Real Estate ETF
VNQI
$3.46B
$265K ﹤0.01%
4,887
NGG icon
342
National Grid
NGG
$82.7B
$262K ﹤0.01%
5,015
IHI icon
343
iShares US Medical Devices ETF
IHI
$3.02B
$255K ﹤0.01%
4,680
TGI
344
DELISTED
Triumph Group
TGI
$251K ﹤0.01%
20,000
ARES icon
345
Ares Management
ARES
$28.5B
$249K ﹤0.01%
5,300
GSK icon
346
GSK
GSK
$103B
$247K ﹤0.01%
5,380
CPRT icon
347
Copart
CPRT
$25.9B
$245K ﹤0.01%
7,700
TTE icon
348
TotalEnergies
TTE
$193B
$245K ﹤0.01%
5,845
-790
-12% -$30.5K
MCRO
349
DELISTED
IQ Hedge Macro Tracker
MCRO
$245K ﹤0.01%
8,650
WDAY icon
350
Workday
WDAY
$33.4B
$240K ﹤0.01%
1,000

Similar funds

Rathbones Group's Q4 2020 Portfolio in Review

As of Q4 2020, Rathbones Group held 400 positions worth $7.04B, up 21% from $5.84B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Rathbones Group deployed $508M of net new capital in Q4 2020, opening 27 new positions and adding to 145 existing holdings. Its largest new stake was Yum China: 456,767 shares worth $26.1M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Boston Scientific, an estimated $6.12M trimmed.

  • Rathbones Group's largest Q4 2020 buy was Yum China: 456,767 shares worth $26.1M.
  • Rathbones Group added most to Align Technology in Q4 2020, an estimated $68.4M increase.
  • Rathbones Group's biggest Q4 2020 reduction was Boston Scientific, cutting an estimated $6.12M.
  • Rathbones Group fully exited LivePerson in Q4 2020, selling an estimated $40.7M.
  • Rathbones Group's ten largest holdings make up 33% of its $7.04B portfolio in Q4 2020.
  • Rathbones Group opened 27 new positions and closed 14 in Q4 2020.
  • Rathbones Group's portfolio value rose 21% quarter-over-quarter to $7.04B.

Based on Rathbones Group's 13F filing for Q4 2020, filed 11 Feb 2021.